Jack Higgins
Equibles does not estimate personal net worth.
Get an email with a short summary when Immunome Inc. publishes a filing, an earnings call transcript or a press release.
Get IMNM alertsAbout Jack Higgins
Immunome Inc. reported in an 8-K filed October 4, 2023 that Jack Higgins was appointed Chief Scientific Officer, effective October 2, 2023. The proxy statement of Immunome Inc. reports total compensation of $1,840,854 for Jack Higgins in fiscal 2023, including a base salary of $107,916. Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.
“Immediately following the effective time of the Merger, Immunome's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Affiliation history
-
Immunome Inc. (IMNM)
Proxy statement
CurrentStart not stated–present
Last confirmed April 24, 2026
Company network
Leadership on record at Immunome Inc.
- Clay B. Siegall, Ph.D. CEO
- Clay Siegall CEO
- Corleen Roche CFO
- Diane Marcou CFO
- Max Rosett CFO
- Matthew K. Robinson CTO
- Sandra Stoneman General Counsel
- Bob Lapetina Chief Accounting Officer
- Carol Schafer Board Member
- Franklyn G. Prendergast, M.D., Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Immunome Inc. (IMNM) | Chief Scientific Officer | $107,916 | $1,840,854 |